Literature DB >> 8408711

Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.

S Casares1, J M Rodríguez, A Martin, A Parrado.   

Abstract

Rearrangements of oncogenes c-myc and c-abl were detected by non-radioactive hybridisation in a case of Burkitt's lymphoma/leukaemia. The surface phenotype of Burkitt's cells were positive for CD19, CD20, HLA-DR, CD14, CD33 and surface immunoglobulin markers. Although cytogenetic analysis was not performed, the c-myc and heavy immunoglobulin genes had the same 14.2 kilobase EcoRI molecular size fragment, suggesting a possible t(8;14) translocation which is a common marker of this malignancy. The c-abl oncogene was also rearranged in DNA digested BamHI and EcoRI. The physiopathological implications of the rearranged c-abl gene are unknown, this being the first case, as for as is known, of Burkitt's lymphoma/leukaemia with a rearranged c-abl gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408711      PMCID: PMC501473          DOI: 10.1136/jcp.46.8.778

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Chromosome studies on normal and leukemic human leukocytes.

Authors:  P C NOWELL; D A HUNGERFORD
Journal:  J Natl Cancer Inst       Date:  1960-07       Impact factor: 13.506

2.  Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

Authors:  D De Jong; B M Voetdijk; G C Beverstock; G J van Ommen; R Willemze; P M Kluin
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

3.  Activation of the c-myc gene by translocation: a model for translational control.

Authors:  H Saito; A C Hayday; K Wiman; W S Hayward; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.

Authors:  J T Lee; D J Innes; M E Williams
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

Review 6.  Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch.

Authors:  S A Stass; J Mirro
Journal:  Clin Haematol       Date:  1986-08

7.  Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.

Authors:  C E Gauwerky; J Hoxie; P C Nowell; C M Croce
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

8.  Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia.

Authors:  D M McCarthy; F V Rassool; J M Goldman; S V Graham; G D Birnie
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

9.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

10.  Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia.

Authors:  C E Gauwerky; K Huebner; M Isobe; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

  10 in total
  1 in total

1.  A Rare Case of ALK-Positive Large B-Cell Lymphoma with CD33 Expression.

Authors:  Jessica Corean; K David Li
Journal:  Case Rep Hematol       Date:  2018-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.